Skip to main content
Medical information Clinical review pending

Diagnostic Testing

Immunophenotyping By Flow Cytometry CD1a Test

The Immunophenotyping By Flow Cytometry CD1a Test helps identify specific blood cancers by analyzing cell surface markers. This test provides valuable information for diagnosing and managing hematological disorders.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
3 mL (minimum 2 mL) of whole blood in a Lavender Top (EDTA) tube and a Green Top (Sodium Heparin) tube, OR 2 mL (minimum 1 mL) of bone marrow in a Green Top (Sodium Heparin) tube.
Results
Confirm with the laboratory before booking.
Preparation
No special preparation is required for this test. Please ensure the sample collection tubes are appropriate as specified.
Test priceKSh 7,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Immunophenotyping By Flow Cytometry CD1a Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Suspected leukemia
  • ✓Suspected lymphoma
  • ✓Evaluation of hematological malignancies
  • ✓Monitoring treatment response
  • ✓Characterization of abnormal blood cells
  • ✓Diagnosis of certain immune disorders
02

In plain language

What this test helps you understand

This test is used to help diagnose certain types of blood cancers, such as leukemia and lymphoma, by identifying specific markers (CD1a) on blood or bone marrow cells. It aids in classifying these conditions and guiding treatment decisions.
The Immunophenotyping By Flow Cytometry CD1a Test is a diagnostic procedure used to help identify certain types of blood cancers. It uses flow cytometry, a technique that analyzes the characteristics of cells, to provide essential information for diagnosis and treatment planning.

This test specifically measures the presence of CD1a markers on the surface of cells. Detecting these markers is important in diagnosing hematological malignancies, such as leukemia and lymphoma.

Individuals experiencing symptoms like persistent fatigue, frequent infections, or unexplained bruising may be advised to consider this test. Those with a family history of blood cancers or previous hematological conditions might also benefit.

This test aids healthcare providers in making timely diagnoses, guiding treatment decisions, and potentially improving patient outcomes. Results are typically available quickly to support clinical decision-making. A healthcare professional will interpret your results and discuss them with you.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo special preparation is required for this test. Please ensure the sample collection tubes are appropriate as specified.
Sample3 mL (minimum 2 mL) of whole blood in a Lavender Top (EDTA) tube and a Green Top (Sodium Heparin) tube, OR 2 mL (minimum 1 mL) of bone marrow in a Green Top (Sodium Heparin) tube.
MethodologyFlow Cytometry
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test identifies the presence or absence of CD1a markers. It may not detect all types of blood cancers or provide a complete picture of the patient's condition. Results must be interpreted in conjunction with other clinical findings and tests. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Immunophenotyping is a laboratory technique used to identify cells based on the markers (antigens) on their surface or inside them. It helps classify cells, especially in blood and bone marrow.
CD1a is a protein found on the surface of certain immune cells. Its presence or absence, along with other markers, helps in diagnosing specific types of blood cancers and immune disorders.
A sample of blood or bone marrow is collected. For blood, it's typically drawn into specific tubes (Lavender Top/EDTA and Green Top/Sodium Heparin). For bone marrow, a small sample is aspirated.
Samples should be shipped immediately at a controlled temperature (18°C to 22°C) and must not be refrigerated or frozen. Please follow the laboratory's specific transport instructions.
A qualified pathologist or haematologist will analyze the results. Your doctor will then discuss the findings and their implications with you.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp